Market Place
Sourcing Support
All News #Library
Biotech
Nxera Pharma Initiates Phase 2 Trial Of NBI-1117570
12 Apr 2026 //
GLOBENEWSWIRE
Boehringer Cuts Ties To Nxera`s Phase 2-Ready Schizophrenia Drug
20 Dec 2025 //
FIERCE BIOTECH
Nxera Pharma Regains Full Rights to GPR52 for Schizophrenia
18 Dec 2025 //
GLOBENEWSWIRE
Nxera Partners Cancer Research UK For Successful Phase 1 Cancer
21 Oct 2025 //
GLOBENEWSWIRE
Nxera Pharma, Cancer Research UK Start Ph 2a Trial of HTL0039732
16 Sep 2025 //
GLOBENEWSWIRE
Nxera Pharma gets US$15M from Neurocrine Biosciences for Phase 3
02 Jun 2025 //
GLOBENEWSWIRE
Nxera Pharma & Antiverse Collaborate on AI-Driven GPCR Therapies
05 Nov 2024 //
GLOBENEWSWIRE
Nxera Pharma Wins Biotech Company and Financing Awards 2024
23 Oct 2024 //
GLOBENEWSWIRE
Nxera Partner Neurocrine Initiates NBI-1117567 Phase 1 Study
09 May 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.